Report overview
Pet pharmaceutical refers specifically to medicines given to pets.
In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.
In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.
This report aims to provide a comprehensive presentation of the global market for Pet Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Pharmaceuticals. This report contains market size and forecasts of Pet Pharmaceuticals in global, including the following market information:
Global Pet Pharmaceuticals Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pet Pharmaceuticals Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pet Pharmaceuticals companies in 2022 (%)
The global Pet Pharmaceuticals market was valued at US$ 14680 million in 2022 and is projected to reach US$ 23120 million by 2029, at a CAGR of 6.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.
We surveyed the Pet Pharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Pharmaceuticals Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pet Pharmaceuticals Market Segment Percentages, by Type, 2022 (%)
Antiparasitic
Biological Products
Antibacterial
Others
Global Pet Pharmaceuticals Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pet Pharmaceuticals Market Segment Percentages, by Application, 2022 (%)
Prevention
Treatment
Global Pet Pharmaceuticals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pet Pharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet Pharmaceuticals revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pet Pharmaceuticals revenues share in global market, 2022 (%)
Key companies Pet Pharmaceuticals sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pet Pharmaceuticals sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pet Pharmaceuticals, market overview.
Chapter 2: Global Pet Pharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of Pet Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pet Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pet Pharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
